CA
NZ
UK
AU
IND
US
Intel Products revenue grew 22%, led by theData Centerand AI group, where revenue rose 78% to $7.3 billion on a richer mix of premium products and, to a lesser extent, demand-based pricing actions. Client Computing revenue was $8.1 billion, down 5% because of lower …
The swing came from other income. Total other loss was $124.4 million, built from a $402.1 million loss on investments that was partly offset by a $277.7 million gain on derivative instruments. The CEO said financial conditions tightened as investors priced in more Federal …
Net income was a record $6.6 million, or $0.86 per diluted share, compared with $5.2 million, or $0.71, in the third quarter of 2025. That included after-tax expenses of $657,000 tied to the proposed Grand River Commerce acquisition.
Medical device sales were $17.4 million, up 21% from $14.4 million, and now make up 85% of the total versus 77%. Orthopedic sales rose 16% to $12.8 million, mainly on the next generation handpiece sold to the largest customer. CMF sales jumped 39% to …
Net productRevenuewas $275.9 million versus $131.0 million, driven by a $162.3 million increase in Sephience, which treats phenylketonuria.Royaltyrevenue rose 15% to $81.7 million on higher Evrysdi sales, while collaboration and license revenue fell to $0.2 million from $9.3 million.
Net sales were $544.5 million, up 10% from $493.8 million. Selling price and product mix contributed about 7%, reflecting pricing actions to offset higher raw material costs and index-based customer contracts, while volumes added about 3% on newBusinesswins across all segments.
Advertising revenue increased $297.7 million, or 54%. The filing says the gain came mainly from pricing, with the price of ads up about 34%, and to a lesser extent from ad impressions delivered, which rose about 15%. U.S. revenue grew 50% and rest of …
Revenue was $4,559 million, up from $4,212 million. Total price contributed 4.7%, made up of averageYieldof 2.9% and fuel recovery fees of 1.8%, while acquisitions net of divestitures added 1.3% andVolumesubtracted 0.6%.
On September 1, 2026, the company completed the sale of its MatrixCareBusinessas part of a portfolio optimization strategy to focus on sleep, breathing and connected home-based care.
Net income rose to $6.5 million from $2.8 million, and diluted EPS was $0.07 compared with $0.03.Operating Incomewas $9.8 million, against $4.4 million a year earlier.
Please wait processing your request...